4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001193125-26-355502
President and CEO sold 48,199 shares at $20.33 ($979,886)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Patel Sanjiv · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-17 | Sale : show line 1 in the form 10b5-1 | −48,199 | $20.33 | $979,886 | 567,699 | D |
| Open-market sales · 48,199 sh · avg $20.33 · $979,886 | ||||||
Loading xslF345X06/ownership.xml…